3
2
1

Yinfeng Cryogenic and Anhui Medical University "Ministry of Education Engineering Research Center" project was accepted and awarded by the Ministry of Education

Release time:

2023-05-17

Led by Anhui Medical University and participated by Yinfeng Cryogenic Medical Technology Co., Ltd., the "Engineering Research Center for Life Resources Conservation and Artificial Organs of the Ministry of Education" was officially accepted and awarded by the Ministry of Education. As one of the four major platforms for the transformation of the center's project, Yinfeng Cryogenic Co., Ltd. is responsible for the "development, promotion and application of cryogenic preservation technology of biological matrix materials".

 

 

On May 16, 2023, the Anhui Provincial Department of Education, organized by the Ministry of Education of the People's Republic of China and led by Academician Qiao Jie of Peking University, conducted an expert demonstration on the task setting and planning of the center, and conducted on-site inspections of a number of experimental centers.

Introduction to the center

"Engineering Research Center for Conservation of Life Resources and Artificial Organs of the Ministry of Education" (hereinafter referred to as the Center) relies on the construction of Anhui Medical University, and Yinfeng Cryogenic Medical Technology Co., Ltd., as the project transformation unit, is the first technology transformation center in China positioned to develop advanced cryopreservation technology, instruments, equipment and systems for life resources.

Facing the major needs of human health and the national biomedical industry development strategy, the center is guided by promoting the development of technology in the field of biomedicine and life and health in China, with the main goal of developing advanced cryopreservation technologies and systems for life resources such as cells, tissues, organs and biomedical materials, and devoting itself to the application and promotion of clinical treatment.

The main task of the center is to establish a multi-scale, all-round and systematic cryopreservation technology system for life resources, and carry out relevant biomedical clinical trials and system development, so as to achieve technology transformation and clinical application.

The construction period of the center is planned to be 3 years, and the construction sites include the Reproductive Center of the First Affiliated Hospital of Anhui Medical University, the School of Biomedical Engineering of Anhui Medical University, the Laboratory of Cryogenic Medicine and Cryomedicine and Micro-Nano Biological System Engineering of the University of Science and Technology of China, Yinfeng Cryogenic Medical Technology Co., Ltd., etc. The main research directions of the center include: fertility cryopreservation and fertility resource bank establishment; development and preservation of artificial organs; advanced cryopreservation technology and system integration; Development and popularization of cryopreservation technology for biological matrix materials.

The construction and development of the "Engineering Research Center for the Conservation of Life Resources and Artificial Organs of the Ministry of Education" adheres to the purpose of "production, learning, research and medicine", and cooperates with experts and professors from various universities and technology development platforms to deepen the integration and cooperation of industry, academia, research and medicine, implement the policy of transformation of scientific research achievements, and promote the better and faster transformation of scientific research results into clinical practice.

Latest developments

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.